Category - Developments

Developments

ANSM grants clearance for Anteris trial of transcatheter heart valve

Anteris Technologies Global (NASDAQ: AVR; ASX: AVR) has received full regulatory clearance from the French National Agency for Medicines and Health Products Safety (ANSM) enabling patient recruitment to begin in France...

June 8, 2026

Developments

MindBio launches AI software for drug use and fatigue detection

MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has launched its lead commercial software Intox AI for validation and testing of intoxication and fatigue. Intox AI enables new analytical capabilities to...

June 5, 2026

Developments

TelyRx commences trading on OTCQX

TelyRx Holdings (TSX: TELY; OTCQX: TELYF) has announced that its subordinate voting shares will commence trading on the OTCQX Best Market (OTCQX), the premier tier of the OTC Markets Group in the U.S., under the symbol...

June 5, 2026

Developments

Profound Medical’s TULSA procedure highlighted on popular podcast, Over 50 & Flourishing

In a recent two-part Over 50 & Flourishing video and podcast, host Dominique Sachse sat down with her husband, voice actor and singer Vic Mignogna, to discuss his health journey, including a diagnosis of prostate...

June 4, 2026

Developments

VolitionRx files patent for Ebola triage and treatment monitoring test

VolitionRx (NYSE AMERICAN: VNRX) has announced the filing of a strategic patent application covering the use of its proprietary Nu.Q technology in triaging and monitoring patients who are suspected of having contracted...

June 3, 2026

Developments

AACN journal publishes study showing benefits of ENvue’s feeding tube guidance platform

ENvue Medical (NASDAQ: FEED) has announced that Critical Care Nurse, the official journal of the American Association of Critical-Care Nurses (AACN), has published an independent, peer-reviewed study showing significant...

June 3, 2026

Developments

Firefly discovers novel electrophysiological biomarker for PTSD

Firefly Neuroscience (NASDAQ: AIFF) has announced the identification of a novel electrophysiological biomarker for Post-Traumatic Stress Disorder (PTSD) using brain scans collected on its FDA-510(k)-cleared Evoke System...

June 2, 2026

Developments

Senzime launches new EMG sensor for anesthesia monitoring

Senzime (STO: SEZI; OTCQX: SNZZF) has announced the launch of its TetraSens electromyography (EMG) sensor for use with the TetraGraph Train-of-Four monitoring system for anesthesia monitoring. According to Senzime, the...

June 1, 2026

Developments

Sunshine announces Canadian approval of generic Rivaroxaban

Sunshine Biopharma (NASDAQ: SBFM) has announced the Canadian approval of Rivaroxaban—its generic equivalent of the brand Xarelto—in tablets of 2.5 mg, 10 mg, 15 mg, and 20 mg for the treatment and prevention of deep...

June 1, 2026

Developments

Cercare and Siemens announce global collaboration on CBCT-P guided stroke treatment

Closely held Cercare Medical and Siemens Healthineers (FSE: SHL) have announced a global collaboration to accelerate the adoption of Cone-Beam CT Perfusion (CBCT-P) in acute stroke care, leveraging its capability to...

May 28, 2026

Category - Developments

Subscribe